Suppr超能文献

药物经济学在当前印度医疗保健系统中的作用。

The role of pharmacoeconomics in current Indian healthcare system.

作者信息

Ahmad Akram, Patel Isha, Parimilakrishnan Sundararajan, Mohanta Guru Prasad, Chung HaeChung, Chang Jongwha

机构信息

Department of Pharmacy Practice, Annamalai University, Annamalai Nagar, Tamil Nadu, India.

Department of Clinical, Social and Administrative Sciences, University of Michigan, Ann Arbor, MI, USA.

出版信息

J Res Pharm Pract. 2013 Jan;2(1):3-9. doi: 10.4103/2279-042X.114081.

Abstract

Phamacoeconomics can aid the policy makers and the healthcare providers in decision making in evaluating the affordability of and access to rational drug use. Efficiency is a key concept of pharmacoeconomics, and various strategies are suggested for buying the greatest amount of benefits for a given resource use. Phamacoeconomic evaluation techniques such as cost minimization analysis, cost effectiveness analysis, cost benefit analysis, and cost utilization analysis, which support identification and quantification of cost of drugs, are conducted in a similar way, but vary in measurement of value of health benefits and outcomes. This article provides a brief overview about pharmacoeconomics, its utility with respect to the Indian pharmaceutical industry, and the expanding insurance system in India. Pharmacoeconomic evidences can be utilized to support decisions on licensing, pricing, reimbursement, and maintenance of formulary procedure of pharmaceuticals. For the insurance companies to give better facility at minimum cost, India must develop the platform for pharmacoeconomics with a validating methodology and appropriate training. The role of clinical pharmacists including PharmD graduates are expected to be more beneficial than the conventional pharmacists, as they will be able to apply the principles of economics in daily basis practice in community and hospital pharmacy.

摘要

药物经济学可以帮助政策制定者和医疗服务提供者在评估合理用药的可承受性和可及性方面进行决策。效率是药物经济学的一个关键概念,人们提出了各种策略,以便在给定的资源使用情况下获得最大数量的益处。药物经济学评估技术,如成本最小化分析、成本效益分析、成本效益分析和成本利用分析,这些技术支持对药物成本的识别和量化,其开展方式类似,但在健康益处和结果的价值衡量方面有所不同。本文简要概述了药物经济学、其在印度制药行业的效用以及印度不断扩大的保险体系。药物经济学证据可用于支持药品许可、定价、报销以及药品处方集程序维护等方面的决策。为了让保险公司以最低成本提供更好的服务,印度必须开发具有验证方法和适当培训的药物经济学平台。包括药学博士毕业生在内的临床药师的作用预计将比传统药师更具益处,因为他们能够在社区和医院药房的日常实践中应用经济学原理。

相似文献

1
The role of pharmacoeconomics in current Indian healthcare system.
J Res Pharm Pract. 2013 Jan;2(1):3-9. doi: 10.4103/2279-042X.114081.
2
Pharmacoeconomics and formulary decision making.
Pharmacoeconomics. 1996;9 Suppl 1:16-25. doi: 10.2165/00019053-199600091-00005.
3
Emerging role of pharmacoeconomics in the research and development decision-making process.
Pharmacoeconomics. 2001;19(7):753-66. doi: 10.2165/00019053-200119070-00004.
4
Overview of pharmacoeconomics and pharmaceutical outcomes evaluations.
Am J Health Syst Pharm. 1995 Oct 1;52(19 Suppl 4):S5-8. doi: 10.1093/ajhp/52.19_Suppl_4.S5.
5
[Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
Wien Med Wochenschr. 2006 Dec;156(23-24):612-8. doi: 10.1007/s10354-006-0357-7.
6
Pharmacoeconomics.
Natl Med J India. 2004 Mar-Apr;17(2):80-3.
7
[Pharmacoeconomics].
Yakugaku Zasshi. 2003 Mar;123(3):133-42. doi: 10.1248/yakushi.123.133.
8
Barriers to implementing pharmacoeconomics: interview study.
Expert Rev Pharmacoecon Outcomes Res. 2021 Feb;21(1):93-104. doi: 10.1080/14737167.2020.1766969. Epub 2020 May 29.
9
Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.
Pharmacoeconomics. 1992 Apr;1(4):265-81. doi: 10.2165/00019053-199201040-00004.

引用本文的文献

1
Using the Physitrack telehealth platform for enhancing pharmacology education in pain management.
Indian J Pharmacol. 2024 Nov 1;56(6):442-443. doi: 10.4103/ijp.ijp_717_24. Epub 2025 Feb 19.
3
Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries.
Int J Environ Res Public Health. 2022 Jun 27;19(13):7862. doi: 10.3390/ijerph19137862.
4
Spinal Muscular Atrophy Therapeutics in India: Parental Hopes and Despair!
Ann Neurosci. 2021 Jul;28(3-4):112-113. doi: 10.1177/09727531211046365. Epub 2021 Oct 3.

本文引用的文献

1
Do consumer-directed health plans drive change in enrollees' health care behavior?
Health Aff (Millwood). 2008 Jul-Aug;27(4):1120-31. doi: 10.1377/hlthaff.27.4.1120.
2
Health plan pay-for-performance strategies.
Am J Manag Care. 2006 Sep;12(9):537-42.
3
Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle.
BMJ. 2004 Oct 23;329(7472):972-5. doi: 10.1136/bmj.329.7472.972.
4
Pharmacoeconomics.
Natl Med J India. 2004 Mar-Apr;17(2):80-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验